title: The clinical evaluation of novel imaging methods for cancer management.
abstract: The National Cancer Institute (NCI) has a long-standing interest in evaluating and using the known advantages of molecular and functional imaging, as well as assessing the potential of novel imaging agents and modalities, to improve clinical cancer research and cancer care. In this Perspectives article, I discuss the strategies and resources being used by the NCI to foster and enhance these evaluations. Although resource and logistical challenges abound in successfully mounting these trials, many examples exist of real and potential solutions to improve the clinical evaluation process for imaging agents and modalities in the USA and in international collaborations.
authors.affiliation: National Cancer Institute, Cancer Imaging Program, Chief Diagnostic Imaging Branch, 6130 Executive Boulevard, Bethesda, MD 20892 7412, USA. shankarl@mail.nih.gov
authors.forename: Lalitha K
authors.initials: LK
authors.lastname: Shankar
mesh_terms: D000818:Animals; D003952:Diagnostic Imaging / Q000379:methods*; D019468:Disease Management; D006801:Humans; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy; D014481:United States